Burcon NutraScience Corporation (TSX-V: BU) announced today that it has engaged Mr. Mark Komonoski of Calgary to perform investor relations services by assisting the Company with communicating its corporate message to financial markets worldwide. Mr. Komonoski will augment the existing Burcon investor relations program.
Mr. Komonoski has more than 20 years experience in the financial community, with a focus on environmentally friendly or socially responsible investment ("SRI") opportunities. For the past five years, he has worked with two SRI companies: JER Envirotech International and Carmanah Technologies Corporation and managed their public market development programs. At Burcon, Mr. Komonoski will work directly with senior management to ensure that financial professionals and investors who specialize in Food Technology investment are made aware of the investment opportunity Burcon represents in this industry category.
"Burcon has a sustainable technology and I look forward to expanding the awareness of Burcon with the financial community." commented Mr. Komonoski.
The Investor Relations Service Agreement (the "Agreement") will have a term of 24 months. The Agreement is also terminable upon 30 days notice by either party. Burcon has agreed to pay Mr. Komonoski $6,000 per month for performing the services under the Agreement and to reimburse him for his reasonable out of pocket expenses. The Company has also granted Mr. Komonoski an option to purchase up to a total of 50,000 Common shares in the capital of Burcon at an exercise price of $6.25 per share. The option will have a term of five years from the date of grant and will vest as to 33 1/3% on the date that is 8, 16 and 24 months from the date of grant, respectively.
Mr. Komonoski currently owns Burcon securities, and may acquire more securities in the future. The Agreement is subject to acceptance by the TSX Venture Exchange.
About Burcon NutraScience
Burcon is research and development company developing a portfolio of composition, application, and process patents around its plant protein
extraction and purification technology. Burcon, in conjunction with Archer Daniels Midland, is commercializing versatile new canola proteins, Puratein(R) and Supertein(TM), with valuable nutritional profiles and each with unique functional properties. Burcon's Puratein(R) and Supertein(TM) are the first canola protein isolates to have attained GRAS status in the United States. Burcon's goal is to develop Puratein(R) and Supertein(TM) to participate in the expanding multi-billion dollar protein ingredient market, with potential uses in functional beverages, prepared foods, and nutritional supplements. Burcon has also developed Clarisoy(TM) a soy protein isolate that is 100% soluble and transparent, even in highly acidic solutions. Burcon expects Clarisoy(TM) to be a next generation soy protein isolate offering all the benefits of soy protein but with minimal impact on the properties of the beverage to which it is added.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information contained
herein. This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our products ,statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words "goal", "intend", "believes" and "potential" and similar expressions, generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized.
For further information: Jade Cheng, Chief Financial Officer, Burcon NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free,
[email protected], www.burcon.ca; AXINO AG, Sven Olsson, Investor Relations Europe, Konigstrasse 26, 70173 Stuttgart, Germany, Tel. +49-711-25 35 92-30, Fax +49-711-25 35 92-33, [email protected], www.burcon.net